Synopsys Crashed 36% — What Investors Need to Know
Wall Street panicked, but Synopsys’ long-term story hasn’t changed - the 36% drop presents an opportunity!
Synopsys is one of the most unique and best-positioned businesses globally, offering one of the most essential and complex products you’ll find, and a real standout in the semiconductor industry.
Simply put, its software is essential for semiconductor designers. Without it, modern semiconductor design would be impossible. Highlighting this, Nvidia CEO and founder Jensen Huang even calls Synopsys’ EDA and IP products “mission-critical” to the company’s business and design process.
You see, Synopsys is the backbone of modern semiconductor design. As the global leader in electronic design automation (EDA) software and a fast-growing provider of semiconductor intellectual property (IP), the company occupies a mission-critical position in the chip development process. Its tools enable semiconductor companies to design, verify, and optimize increasingly complex, high-performance chips—an essential capability in the age of AI, advanced nodes, and system-on-chip architectures.
Synopsys’ EDA software not only allows customers to design their chips from a digital standpoint but also from a physics standpoint, as semiconductor technologies are increasingly pushing the boundaries of physics nowadays. This means this software is multi-dimensional and insanely complicated, as well as unmissable. They enable designers to create precise circuit schematics, simulate how a chip will function under different conditions, and detect potential flaws before fabrication.
The company effectively operates a duopoly in EDA alongside Cadence, holding a growing mid-30s market share protected by decades of accumulated innovation that creates an insurmountable moat for new entrants. At the same time, Synopsys’ semiconductor IP portfolio continues to gain ground on ARM, expanding market share and accelerating customer adoption.
This dual exposure provides both stability and growth, reinforced by a subscription-based revenue model, a non-cancellable backlog of over $10 billion, and enviable geographic diversification, with no single region accounting for over 50% of revenue and minimal exposure to China.
Most importantly, as semiconductors become increasingly complex, customers cannot operate without Synopsys’ software and IP. This drives consistency - Synopsys has reported only three quarters of negative growth in well over a decade - while also underpinning a compelling long-term growth outlook. Positioned at the intersection of rising semiconductor complexity, AI-driven design, and the need for standardized IP, Synopsys is one of the most attractive compounders in the semiconductor ecosystem.
That backdrop makes its latest earnings all the more striking. Despite its enviable position and resilient business model, Synopsys stumbled in its fiscal Q3 results, delivering numbers that fell well short of expectations and rattled investors, to say the least.
Last Tuesday, Synopsys reported its fiscal Q3 results — and the numbers were nothing short of disappointing. Revenue and earnings both came in significantly below consensus, and management compounded the miss by providing profit guidance that was nearly 20% under Street expectations.
The biggest concern, however, lies in what drove the weakness. The shortfall was concentrated in the company’s semiconductor IP segment, where Synopsys is now facing meaningful headwinds, both external and internal. What unsettles Wall Street most is the uncertainty surrounding this: are we looking at a temporary setback or the early signs of a more structural issue? It appears to be a combination of both, but opinions differ, and uncertainty persists, which affects investor sentiment.
The market’s verdict was brutal. Shares collapsed 36% on Wednesday, marking the steepest single-day decline in Synopsys’ history. A combination of lofty pre-earnings expectations and the scale of the profit guidance miss amplified the sell-off.
With this reset, I think it’s the right time to revisit my Synopsys investment thesis — digging into the results and developments, re-examining its long-term drivers, updating my financial estimates, and asking whether the stock’s sharp correction has created an opportunity or revealed a deeper concern – is my thesis falling apart amid structural issues, or is Wall Street overreacting?
Let’s delve right in!
Welcome to InvestInsights — an independent equity research publication rooted in long-term, buy-and-hold investing, publishing actionable stock/equity research reports weekly!
📈 You’re reading my latest [FREE] stock analysis. If you like this analysis, make sure to like & subscribe to receive much more like this!
If you’d like full portfolio access (14% CAGR since 2022) & additional exclusive reports, consider becoming a paid subscriber!
Synopsys faces unexpected headwinds, impacting its Q3 numbers
Q3 was an uncharacteristic quarter for Synopsys, which is generally a reliable performer, but not in the last quarter. The company failed to meet consensus estimates by quite a margin, missing the profit consensus by 10% amid a combination of unexpected headwinds in its IP business and a challenging geopolitical backdrop.
At the same time, against this challenging backdrop, the company’s EDA business outperformed expectations, driven by healthy demand. Additionally, Synopsys closed its acquisition of Ansys and expanded its customer base.
Jumping right into the results, Synopsys reported Q3 revenue of $1.74 billion, up 14% YoY, driven by the excellent performance in EDA, but held back by negative growth in IP revenue.
By region, the company saw strength in Europe and North America. However, weakness in China persisted, despite a sequential improvement, which is still essentially the result of the 6-week export ban that affected the company earlier this year. Yes, the actual restrictions only lasted 6 weeks, but the effects still linger due to changed customer behavior. Here’s how management put it:
“Customers were questioning whether or not they will invest in a multiyear commitment with Synopsys, how broad will they make that investment? If they start an investment in a chip, can they finish it? Can they tape it out?”
This makes sense. China-based customers are hesitant to sign a large contract with Synopsys, given their awareness of the risk of new restrictions that could significantly impact their chip development. As a result, the impact of that sudden 6-week ban is much larger than it appears, and this weakness could continue to affect results throughout the remainder of 2025 and into 2026.
On a more positive note, Synopsys reported a healthy performance in backlog, coming in at $10.1 billion, roughly flat from the start of the year, thanks to a small contribution from Ansys and robust demand, with Synopsys continuing to sign long-term contracts.
Breaking down revenue by segment, Synopsys’ EDA operations performed really well, and better than expected, growing revenue by 23% YoY to $1.31 billion. According to management, this was “led by strength in hardware as the complexity of designing silicon for AI workloads drives demand for Synopsys’ powerful emulation and prototyping solutions.” Initial adoption and customer response to the integration of Ansys’s systems have also been outstanding!
This strength underscores the resiliency of the EDA business, which continues to deliver consistent growth despite broader semiconductor cyclicality. On the earnings call, management emphasized that Q3 results “reinforce [Synopsys’] leadership in next-generation chip design,” highlighting several essential dynamics:
The company is winning competitive bids for full-flow digital implementations, including a multiyear commitment with a leading AI customer — a sign that Synopsys is not just defending market share but actively expanding it.
Its sign-off and extraction platforms remain the industry standard, with broader customer adoption and successful tape-outs at advanced nodes, demonstrating the stickiness of its ecosystem.
Most importantly, AI-focused design capabilities are emerging as a key differentiator, with Synopsys leveraging its hardware emulation and prototyping strength to capture incremental demand as chipmakers race to design increasingly complex AI accelerators.
Put simply, the EDA segment continues to validate Synopsys’ moat: a combination of best-in-class technology, deep integration into customer R&D workflows, and the scale required to support advanced chip development. With AI complexity now acting as an additional growth catalyst, EDA remains the company’s crown jewel and the foundation of its long-term thesis, accounting for 75% of Synopsys’ revenue.
Looking ahead, the long-term appeal of the EDA market is hard to overstate. Every new wave of semiconductor innovation — whether it’s AI accelerators, autonomous driving chips, 5G connectivity, or advanced system-on-chip designs — brings exponential complexity. Modern chips now contain billions of transistors, making it impossible to design them by hand. This rising complexity ensures that demand for EDA tools not only grows but becomes increasingly non-negotiable for chipmakers. Furthermore, the secular drivers powering semiconductors — AI, electrification, cloud, and edge computing — all require more advanced chips, which in turn necessitate more advanced design tools. With only two companies (Synopsys and Cadence) capable of meeting these needs at scale, Synopsys is positioned to grow steadily for years, if not decades, making it one of the most attractive and durable parts of the semiconductor value chain.
Synopsys is still in the prime position to benefit.
At the same time, there isn’t as much enthusiasm for Synopsys’ Design IP operations, which are struggling, recording revenue of $428 million, down 8% YoY in Q3, which is about $120 million less than guided for and counted on by Wall Street. This led to heavy disappointment, mainly because it was somewhat unexpected.
Driving the YoY decline and surprising guidance miss were three factors of both external and internal nature. First of all, there were the headwinds in China, which I just mentioned, that significantly hurt its IP business, leading to some deals not finalizing as anticipated.
Second, there is the ongoing turbulence at Intel. Intel has long been one of Synopsys’ most important customers, consistently accounting for around 10% of revenue, making it by far the company’s single largest client relationship. This deep link means Intel’s challenges inevitably ripple through to Synopsys.
Management explained that Synopsys made a significant investment in building out its IP portfolio for Intel’s foundry ambitions, with the expectation that those efforts would start to pay off meaningfully in the second half of fiscal 2025. That payoff, however, has failed to materialize, mainly due to issues beyond Synopsys’ control — namely, Intel’s repeated execution struggles in its foundry business.
Intel’s difficulties in catching up with TSMC and stabilizing its manufacturing roadmap have created uncertainty not only for its own product launches but also for key partners, such as Synopsys, which were counting on higher volumes and broader adoption of Intel’s foundry services. As a result, the return on Synopsys’ IP investment into this relationship is now delayed, contributing to the current weakness in its IP revenue.
However, while this headwind is painful in the near term, it’s important to note that Intel’s role as a strategic customer does not appear to be shrinking. Instead, the issue is one of timing: Intel’s roadmap delays are pushing out revenue recognition for Synopsys, reinforcing the stock’s short-term volatility but not necessarily undermining the long-term opportunity.
And thirdly, Synopsys internally made specific road map and resource decisions that did not yield their intended results. Additionally, management is pivoting its IT resources and road map towards the highest growth opportunities, which is a short-term drag.
For context, semiconductor intellectual property (IP) refers to pre-designed, pre-verified building blocks that chipmakers can license and integrate into their designs, eliminating the need to build everything from scratch. These blocks include essential components such as memory interfaces, processors, or high-speed connectivity standards like PCIe and Ethernet. By utilizing licensed IP, customers can save years of development time and reduce risk, thereby accelerating their time-to-market while ensuring reliability.
Historically, Synopsys’ IP business was rooted in selling these smaller, individual IP blocks. However, the company is now evolving toward larger, integrated solutions — such as subsystems (collections of IP bundled and validated together) and chiplets (modular silicon blocks that can be combined to build advanced semiconductors). This shift is being driven by AI and data center workloads, which demand faster connectivity and greater design efficiency. By moving up the value chain into these higher-value solutions, Synopsys strengthens its leadership in interface IP and positions itself for long-term growth across AI, HPC, automotive, and edge markets — a crucial move to maintain both market share and relevance.
Yet, this transition comes with short-term trade-offs. Redirecting resources away from legacy IP offerings and toward higher-value opportunities has weighed on near-term performance. Still, this is not a sign of structural weakness — instead, it’s an investment in aligning Synopsys’ IP portfolio with where the industry is headed.
For now, I see no reason to assume this weakness to be structural. Yes, these near-term issues are significant, but I expect them to ease in due time, although this may take until at least halfway through 2026.
On that note, let’s move to the bottom-line performance, which suffered under the combination of underperformance in IP and higher operating costs related to the Ansys acquisitions.
Synopsys reported total operating expenses of $1.07 billion, up 37% YoY, mainly driven by these ANSYS-related costs and investments in IP operations, leading to almost a doubling in G&A expenses.
As a result, the operating margin fell 150 bps YoY to 38.5%, reflecting the higher costs and lower IP revenue. Crucially, this short-term headwind does nothing to alter Synopsys’ long-term margin commitment, which remains a targeted mid-40s operating margin.
Further down the line, this lower operating margin led to some pressure on EPS as well, as this fell 1% YoY to $3.39.
Finally, FCF was $632 million at a 36% FCF margin, which held up remarkably well, all things considered.
This allowed Synopsys to improve its balance sheet, which had worsened significantly due to the Ansys acquisition closing. Synopsys ended the quarter with $2.6 billion in cash and total debt of $14.3 billion, leaving it in a considerable net debt position, as opposed to a net cash position before the acquisition.
Positively, Synopsys has excellent FCF generation, generating roughly $1.5 billion annually, of which most can be used to pay down debt in the coming years, so I am not too concerned.
Want more out of your subscription? Even more content like this weekly?
Consider InvestInsights PRO - $7.50/month ($70/annually)
This gets you:
A guaranteed 6+ stock analyses every month (roughly 2-4 paid-exclusive).
Full insight into my own portfolio (14% return CAGR since 2022).
Instant transaction alerts anytime I make a move (Fully transparent).
A complete overview of all my target prices and ratings (online available).
Exclusive access to the PRO subscribers Discord channel.
You will get immediate access to these recent analysis of Netflix, American Express, PayPal, Uber, and Meta!
Outlook & Valuation
Moving to the outlook, this is where the real disappointment was, as current headwinds are expected to persist in H2 and into 2026.
However, first, there are some other things to consider. First of all, Synopsys is undergoing a strategic transformation, having divested its Software Integrity Group and acquired Ansys, with a focus on its highest growth opportunities, primarily its EDA expertise. Here is what management said:
“With Ansys, we are now the leader in engineering solutions from silicon to systems. We've expanded our opportunity, broadened our portfolio and increased the resiliency of our business. We remain focused on maintaining our leadership position while pioneering new solutions that will shape the next wave of innovation.”
As part of this strategic pivot, the company will reduce its headcount by approximately 10% by the end of fiscal year 2026 to reallocate resources and optimize its cost structure.
Moving on to the outlook, management is now taking a very conservative view of Q4 amid expectations for headwinds to persist, which has prompted management to fully de-risk its fiscal FY25 outlook, cutting targets for revenue, operating margin, EPS, and free cash flow.
This new outlook now fully prices in the expectation that external headwinds will remain and the internal transformation will take some time. Positively, the outlook seems to leave room for upside.
Management now guides for:
FY25 revenue of $7.03 billion to $7.06 billion, up 15% YoY and ahead of a $6.74 billion consensus.
Full-year operating costs are expected to be roughly $4.4 billion.
Non-GAAP EPS should be between $12.76 and $12.80, down 3% YoY at the midpoint and well short of a $15.13 consensus.
FCF of roughly $950 million, down YoY due to lower revenue and the interest impact of cash utilization and additional debt for the Ansys acquisition.
Obviously, this is a weak outlook, well short of expectations on profit, urging analysts to cut estimates and putting pressure on the stock price.
Looking ahead to 2026, management also expects a muted year in IP due to lingering headwinds. At the same time, management remains committed to its long-term targets, still aiming for double-digit EDA growth, mid-teens IP growth, a mid-40s operating margin, a mid-30s FCF margin, and high-teens EPS growth.
As for my own projections, the 2025 headwinds obviously force me to cut my profit estimates, although I expect management’s guidance to be overly conservative, so I am slightly more optimistic. At the same time, revenue guidance remains strong, so I am actually increasing my revenue estimate, which also takes into account the Ansys acquisition. I am now expecting revenue growth of 15% and a 3% decline in EPS.
For FY26, headwinds are expected to persist, likely resulting in flat IP growth, while EDA is projected to grow by roughly high teens. Additionally, there is the first full year of revenue contribution from Ansys, which will give Synopsys a boost. Meanwhile, I expect IP struggles to drag on the bottom-line performance.
Beyond 2026, I remain very optimistic. I still view Synopsys as excellently positioned to benefit from secular trends in the semiconductor industry. Therefore, I still project stable mid-teens revenue growth through 2030 and low-twenties EPS growth, as margins recover and headwinds ease.
These assumptions are reflected in the projections below.
All things considered, we can safely say that the 36% sell-off on Wednesday was a massive overreaction to unexpected short-term headwinds. Yes, particularly profits are coming in much lower for the year than expected, but the long-term thesis here isn’t broken in the slightest – Synopsys is still a very high-quality business with a mission-critical product offering, poised to fully benefit from favorable secular developments in the semiconductor industry.
Synopsys’ long-term targets remain unchanged and look excellent, as does its medium-term outlook.
Positively, for long-term-oriented investors who remain entirely focused on the fundamentals and ignore short-term panic, these kinds of overreactions offer great opportunities.
Prior to the earnings release, Synopsys shares were trading at a lofty earnings multiple of over 40x. Yet, with shares dropping 36% on Wednesday, we are looking at much more favorable multiples for this best-in-class business today. Yes, shares have already bounced back quite a bit in Thursday’s and Friday’s trading sessions, regaining 10%, but shares are still much cheaper than before.
At today’s share price of $425, Synopsys shares now trade at:
33x this year’s earnings and 30x next year’s earnings.
A growth-adjusted PEG of 1.8x – 24% below the 5-year average.
I know, this is still far from cheap, but you should consider the kind of quality and reliability you are acquiring. With just three quarters of negative growth in over a decade and the company one of the best positioned for the decade ahead in the semiconductor industry, while also facing limited competition, it makes sense that it trades at a premium.
Historically, any time you could acquire shares at a minor discount, it turned out to be an excellent time to buy. I don’t think this time is any different, with nothing fundamentally changed.
For reference, I still believe that assuming a 34x 2027 exit multiple is fair, if not conservative, and using my current estimates, I calculate a 2-year target price of $587. Based on current prices, this represents potential annualized returns of approximately 15.5%.
Honestly, considering the conservatism in these estimates and the healthy projected returns, I believe the risk-reward at $425 is quite good. 15.5% annualized returns should easily outperform global benchmarks, and this is based on financial projections and exit multiples that leave plenty of room for additional upside – this is excellent value in my book.
Below $430, I view SNPS shares as an excellent buy-the-dip opportunity, while below $450, it remains a reasonable DCA price.
For now, I will keep loading up on weakness!
Rating: Buy - Accumulate below $430
2027 Target Price: $587
Implied CAGR from current price: ~15.5%
Please leave a like if you enjoyed this post and found it valuable!
The 36% crash looks dramatic on the chart, but context is important in my opinion: Synopsys is still basically a toll road for chip design. Three quarters of negative growth in over a decade is a ridiculous level of consistency. The IP headwinds are painful, sure, but EDA is the crown jewel and it’s not going anywhere. Below $430, you’re getting paid to hold one of the most entrenched duopolies in semis while Wall Street panics over short-term noise.
Great analysis as ever. The debt and Intel's continuing woes are a concern but overall a good opportunity to buy at a more reasonable price (albeit still a tad pricey)